High-Contrast Luminescent Immunohistochemistry Using PEGylated Lanthanide Complexes

Fei Su1,2, Xiongjian Luo1, Zhongbo Du1

  • 1UTS-SUSTech Joint Research Centre for Biomedical Materials and Devices, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.

Analytical Chemistry
|December 5, 2022
PubMed

Insights

This study enhances immunohistochemistry (IHC) contrast using bright, long-lifetime lanthanide probes and time-gated imaging. This method improves the detection of biomarkers like HER2 in tissue samples.

Area of Science:

  • Biomedical imaging
  • Molecular pathology
  • Nanotechnology

Background:

  • Immunohistochemistry (IHC) offers high resolution but suffers from limited contrast due to probe brightness and tissue autofluorescence.
  • Autofluorescence in biological tissues significantly hinders the sensitivity of conventional fluorescent imaging techniques.

Purpose of the Study:

  • To enhance imaging contrast in immunohistochemistry by developing novel high-density labeled lanthanide probes.
  • To overcome the limitations of autofluorescence and improve the detection of low-abundance biomarkers in tissue sections.

Main Methods:

  • High-density labeling of long-lifetime lanthanide complexes, specifically seven europium complexes conjugated to an eight-arm hydrophilic poly(ethylene glycol) (PEG) linker.
  • Utilizing time-gated imaging to minimize background autofluorescence and amplify signal from the lanthanide probes.
  • Demonstrating compatibility with tyramide signal amplification (TSA) for further signal enhancement.

Main Results:

  • Achieved signal amplification and improved water solubility (up to 10 mg/mL) of the lanthanide probes due to PEGylation.
  • Enhanced contrast by 2-fold for human epidermal growth factor receptor 2 (HER2) in FFPE tissues and 3-fold for cytokeratin 18 (CK18) in frozen sections.
  • Successfully visualized biomarkers with improved sensitivity and reduced background noise.

Conclusions:

  • The developed high-density labeled lanthanide probes combined with time-gated imaging significantly improve IHC contrast and sensitivity.
  • This approach offers a promising strategy for the sensitive detection of low-abundance biomarkers in complex tissue environments.
  • The method holds potential for advancing diagnostic capabilities in pathology and molecular imaging.